Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-19

Clinical Trial Update: Effect of Levocarnitine Plus Myoinositol Versus Myoinositol Alone on Hormonal and Insulin Resistance in PCOS Women [NA]

View source ↗

Summary

ClinicalTrials.gov update describing a study comparing levocarnitine plus myo-inositol versus myo-inositol alone in women with polycystic ovary syndrome, assess…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVOCARNITINE (levocarnitine)
  • Myoinositol (myo-inositol)

Snippet

Sponsor: Mst.Sumyara Khatun | Conditions: Polycystic Ovary Syndrome (PCOS) | NA | Status: RECRUITING